Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases

References

• Lott WA, Bergeim FH. 2-(p-Aminobenzenesulfonamido)-thiazole: a new chemotherapeutic agent. J Am Chem Soc 1939;61:3593–4.
   Google Scholar
• Ball AP, Geddes AM, Davey PG, et al. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet 1980;1:620–3.
   PubMed Web of Science ®Google Scholar
• Oslob JR, Allen DA, Baskaran S, et al. Discovery of a potent and selective aurora kinase inhibitor. Bioorg Med Chem Lett 2008;18:4880–4.
   PubMed Web of Science ®Google Scholar
• Claussen CA, Long EC. Nucleic acid recognition by metal complexes of bleomycin. Chem Rev 1999;99:2797–816.
   PubMed Web of Science ®Google Scholar
• Tricot G, Jayaram HN, Weber G, et al. Tiazofurin: biological effects and clinical uses. Int J Cell Clon 1990;8:161–70.
   PubMedGoogle Scholar
• Hara M, Asano K, Kawamoto I, et al. Leinamycin, a new antitumor antibiotic from streptomyces: producing organism, fermentation and isolation. J Antibiot 1989;42:1768–74.
   PubMed Web of Science ®Google Scholar
• Kempf DJ, Marsh KC, Denissen JF, et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci USA 1995;92:2484–8.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Distinto S, Corona A, et al. Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase. J Enzyme Inhib Med Chem 2017;32:130–6.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Distinto S, Corona A, et al. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase. Eur J Med Chem 2015;93:452–60.
   PubMed Web of Science ®Google Scholar
• Corona A, Meleddu R, Esposito F, et al. Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6. PLoS One 2016;11:e0147225.
   PubMed Web of Science ®Google Scholar
• Distinto S, Maccioni E, Meleddu R, et al. Molecular aspects of the RT/drug interactions. perspective of dual inhibitors. Curr Pharm Design 2013;19:1850–9.
   PubMed Web of Science ®Google Scholar
• Distinto S, Esposito F, Kirchmair J, et al. Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach. Eur J Med Chem 2012;50:216–29.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Distinto S, Corona A, et al. Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida. J Enzyme Inhib Med Chem 2016;31:1672–7.
   PubMed Web of Science ®Google Scholar
• Ojika M, Suzuki Y, Tsukamoto A, et al. Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. J Antibiot 1998;51:275–81.
   PubMed Web of Science ®Google Scholar
• Marquez BL, Watts KS, Yokochi A, et al. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. J Nat Prod 2002;65:866–71.
   PubMed Web of Science ®Google Scholar
• Costa FH, Rosso AL, Maultasch H, et al. Depression in Parkinson's disease: diagnosis and treatment. Arquivos de Neuro-Psiquiatria 2012;70:617–20.
   PubMed Web of Science ®Google Scholar
• Chimenti F, Maccioni E, Secci D, et al. Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones. J Med Chem 2008;51:4874–80.
   PubMed Web of Science ®Google Scholar
• Willcox RR. Treatment of vaginal trichomoniasis with aminitrozole and trichomycin given orally. Gynaecologia 1960;149:122–7.
   PubMedGoogle Scholar
• Domsic JF, Avvaru BS, Kim CU, et al. Entrapment of carbon dioxide in the active site of carbonic anhydrase II. J Biol Chem 2008;283:30766–71.
   PubMed Web of Science ®Google Scholar
• Boron WF. Evaluating the role of carbonic anhydrases in the transport of HCO3−-related species. Biochimica et Biophysica Acta 2010;1804:410–21.
   PubMed Web of Science ®Google Scholar
• Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681–715.
   PubMed Web of Science ®Google Scholar
• Horie K, Kawakami K, Fujita Y, et al. Exosomes expressing carbonic anhydrase 9 promote angiogenesis. Biochem Biophys Res Commun 2017;492:356–61.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• McIntyre A, Hulikova A, Ledaki I, et al. Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth. Cancer Res 2016;76:3744–55.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhao JH, Wang XL, et al. Correlation between carbonic anhydrase IX (CA-9), XII (CA-12) and hypoxia inducible factor-2α (HIF-2α) in breast cancer. Neoplasma 2015;62:456–63.
   PubMed Web of Science ®Google Scholar
• Imtaiyaz Hassan M, Shajee B, Waheed A, et al. Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem 2013;21:1570–82.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of carbonic anhydrase IX as a novel anticancer mechanism. World J Clin Oncol 2012;3:98–103.
   PubMedGoogle Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metast Rev 2007;26:299–310.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mokhtari RB, Pan J, et al. Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors. Am J Respir Cell Mol Biol 2015;52:183–92.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Maccioni E, Distinto S, et al. New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulphonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII. Bioorg Med Chem Lett 2015;25:3281–4.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ceruso M, et al. Amido/ureidosubstituted benzenesulphonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. Eur J Med Chem 2016;110:259–66.
   PubMed Web of Science ®Google Scholar
• Ceruso M, Bragagni M, AlOthman Z, et al. New series of sulphonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII. J Enzyme Inhib Med Chem 2015;30:430–4.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin Ther Pat 2003;13:1545–50.
   Web of Science ®Google Scholar
• Picard F, Deshaies Y, Lalonde J, et al. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes. Res 2000;8:656–63.
   PubMedGoogle Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810.
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
• Pala N, Micheletto L, Sechi M, et al. Carbonic anhydrase inhibition with benzenesulphonamides and tetrafluorobenzenesulphonamides obtained via click chemistry. ACS Med Chem Lett 2014;5:927–30.
   PubMed Web of Science ®Google Scholar
• Suthar SK, Bansal S, Lohan S, et al. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulphonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Eur J Med Chem 2013;66:372–9.
   PubMed Web of Science ®Google Scholar
• Guzel-Akdemir O, Akdemir A, Karali N, et al. Discovery of novel isatin-based sulphonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem 2015;13:6493–9.
   PubMed Web of Science ®Google Scholar
• Ibrahim HS, Abou-Seri SM, Tanc M, et al. Isatin-pyrazole benzenesulphonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII. Eur J Med Chem 2015;103:583–93.
   PubMed Web of Science ®Google Scholar
• Melis C, Meleddu R, Angeli A, et al. Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2017;32:68–73.
   PubMed Web of Science ®Google Scholar
• Bianco G, Meleddu R, Distinto S, et al. N-Acylbenzenesulphonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms. ACS Med Chem Lett 2017;8:792–6.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Distinto S, Cottiglia F, et al. Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulphonamides. ACS Med Chem Lett 2018;9:1045.
   PubMed Web of Science ®Google Scholar
• Melis C, Distinto S, Bianco G, et al. Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors. ACS Med Chem Lett 2018;9:725–9.
   PubMed Web of Science ®Google Scholar
• Schrödinger LLC, New York, NY. 2018.
   Google Scholar
• Mohamadi F, Richards NG, Guida WC, et al. MacroModel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 1990;11:440–67.
   Web of Science ®Google Scholar
• Cho AE, Guallar V, Berne BJ, et al. Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach. J Comput Chem 2005;26:915–31.
   PubMed Web of Science ®Google Scholar
• Chung JY, Hah JM, Cho AE. Correlation between performance of QM/MM docking and simple classification of binding sites. J Chem Inform Model 2009;49:2382–7.
   PubMed Web of Science ®Google Scholar
• Jorgensen WL. OPLS force fields. In Schleyer PvR, ed. Encyclopedia of Computational Chemistry. New York: Wiley; 1998:1986–9.
   Google Scholar
• Akbaba Y, Akıncıoğlu A, Göçer H, et al. Carbonic anhydrase inhibitory properties of novel sulphonamide derivatives of aminoindanes and aminotetralins. J Enzyme Inhib Med Chem 2014;29:35–42.
   PubMed Web of Science ®Google Scholar
• Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Senturk M, Gulcin I, Beydemir S, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494–9.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Petrikaite V, Distinto S, et al. Investigating the anticancer activity of isatin/dihydropyrazole hybrids. ACS Med Chem Lett 2018;10:571–6.
   PubMed Web of Science ®Google Scholar